Tsumura & Co. (TYO:4540)

Market Cap	332.92B
Revenue (ttm)	171.79B
Net Income (ttm)	27.12B
Shares Out	75.94M
EPS (ttm)	357.20
PE Ratio	12.27
Forward PE	10.56
Dividend	136.00 (3.04%)
Ex-Dividend Date	Mar 28, 2025

Volume	366,900
Average Volume	563,655
Open	4,393.00
Previous Close	4,370.00
Day's Range	4,383.00 - 4,465.00
52-Week Range	3,316.00 - 5,138.00
Beta	-0.02
RSI	48.89
Earnings Date	May 12, 2025

About Tsumura & Co.

Tsumura & Co. manufactures and sells pharmaceutical products from crude drugs derived from plants and other natural products in Japan and internationally. The company offers Kampo extract intermediates, granular and prescription Kampo formulations, over-the-counter Kampo medicine, other medications, and herbal bath salts. It offers its products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation, hemorrhoid, body aches, cold, cough, nasal/throat inflammation, children's sickness, stress, an...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1893
• Employees: 4,138
• Stock Exchange: Tokyo Stock Exchange
• Ticker Symbol: 4540

Financial Performance

In 2023, Tsumura & Co.'s revenue was 150.85 billion, an increase of 7.71% compared to the previous year's 140.04 billion. Earnings were 16.71 billion, an increase of 1.37%.